Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1954 3
1956 4
1957 1
1958 4
1959 7
1960 2
1961 10
1962 21
1963 16
1964 16
1965 30
1966 32
1967 28
1968 33
1969 42
1970 38
1971 41
1972 28
1973 31
1974 39
1975 41
1976 36
1977 58
1978 58
1979 60
1980 56
1981 61
1982 56
1983 83
1984 73
1985 105
1986 108
1987 97
1988 125
1989 156
1990 145
1991 169
1992 174
1993 190
1994 221
1995 176
1996 232
1997 205
1998 226
1999 174
2000 203
2001 248
2002 311
2003 286
2004 274
2005 238
2006 286
2007 304
2008 284
2009 317
2010 355
2011 423
2012 418
2013 453
2014 510
2015 522
2016 561
2017 597
2018 616
2019 658
2020 715
2021 834
2022 321
Text availability
Article attribute
Article type
Publication date

Search Results

11,993 results
Results by year
Filters applied: . Clear all
Page 1
[Glioblastoma].
Tanaka S. Tanaka S. No Shinkei Geka. 2021 May;49(3):623-631. doi: 10.11477/mf.1436204436. No Shinkei Geka. 2021. PMID: 34092568 Japanese.
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group. Ogo T, et al. Among authors: tanaka s. Eur Respir J. 2021 Nov 25:2101694. doi: 10.1183/13993003.01694-2021. Online ahead of print. Eur Respir J. 2021. PMID: 34824052
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia.
Kozawa K, Sekai M, Ohba K, Ito S, Sako H, Maruyama T, Kakeno M, Shirai T, Kuromiya K, Kamasaki T, Kohashi K, Tanaka S, Ishikawa S, Sato N, Asano S, Suzuki H, Tanimura N, Mukai Y, Gotoh N, Tanino M, Tanaka S, Natsuga K, Soga T, Nakamura T, Yabuta Y, Saitou M, Ito T, Matsuura K, Tsunoda M, Kikumori T, Iida T, Mizutani Y, Miyai Y, Kaibuchi K, Enomoto A, Fujita Y. Kozawa K, et al. Among authors: tanaka s. Curr Biol. 2021 Jul 26;31(14):3086-3097.e7. doi: 10.1016/j.cub.2021.04.078. Epub 2021 Jun 3. Curr Biol. 2021. PMID: 34087104
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T; HAYABUSA Study Group. Kobayashi T, et al. Among authors: tanaka s. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):429-437. doi: 10.1016/S2468-1253(21)00062-5. Epub 2021 Apr 20. Lancet Gastroenterol Hepatol. 2021. PMID: 33887262 Clinical Trial.
Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels.
Suzuka J, Tsuda M, Wang L, Kohsaka S, Kishida K, Semba S, Sugino H, Aburatani S, Frauenlob M, Kurokawa T, Kojima S, Ueno T, Ohmiya Y, Mano H, Yasuda K, Gong JP, Tanaka S. Suzuka J, et al. Among authors: tanaka s. Nat Biomed Eng. 2021 Aug;5(8):914-925. doi: 10.1038/s41551-021-00692-2. Epub 2021 Mar 29. Nat Biomed Eng. 2021. PMID: 33782572
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K, Arita H, Satomi K, Yamasaki K, Matsushita Y, Nakamura T, Miyakita Y, Umehara T, Kobayashi K, Tamura K, Tanaka S, Higuchi F, Okita Y, Kanemura Y, Fukai J, Sakamoto D, Uda T, Machida R, Kuchiba A, Maehara T, Nagane M, Nishikawa R, Suzuki H, Shibuya M, Komori T, Narita Y, Ichimura K. Fujimoto K, et al. Among authors: tanaka s. Acta Neuropathol. 2021 Aug;142(2):323-338. doi: 10.1007/s00401-021-02337-9. Epub 2021 Jun 20. Acta Neuropathol. 2021. PMID: 34148105
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study.
Tsukita Y, Yamamoto T, Mayahara H, Hata A, Takeda Y, Nakayama H, Tanaka S, Uchida J, Usui K, Toyoda T, Tamiya M, Morimoto M, Oya Y, Kodaira T, Miyauchi E, Jingu K, Sugiura H. Tsukita Y, et al. Among authors: tanaka s. Radiother Oncol. 2021 Jul;160:266-272. doi: 10.1016/j.radonc.2021.05.016. Epub 2021 May 21. Radiother Oncol. 2021. PMID: 34023330
Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Ishikawa H, Mutoh M, Sato Y, Doyama H, Tajika M, Tanaka S, Horimatsu T, Takeuchi Y, Kashida H, Tashiro J, Ezoe Y, Nakajima T, Ikematsu H, Hori S, Suzuki S, Otani T, Takayama T, Ohda Y, Mure K, Wakabayashi K, Sakai T. Ishikawa H, et al. Among authors: tanaka s. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):474-481. doi: 10.1016/S2468-1253(21)00018-2. Epub 2021 Apr 2. Lancet Gastroenterol Hepatol. 2021. PMID: 33812492 Clinical Trial.
Colonoscopy screening and surveillance guidelines.
Saito Y, Oka S, Kawamura T, Shimoda R, Sekiguchi M, Tamai N, Hotta K, Matsuda T, Misawa M, Tanaka S, Iriguchi Y, Nozaki R, Yamamoto H, Yoshida M, Fujimoto K, Inoue H. Saito Y, et al. Among authors: tanaka s. Dig Endosc. 2021 May;33(4):486-519. doi: 10.1111/den.13972. Dig Endosc. 2021. PMID: 33713493 Review.
11,993 results
You have reached the last available page of results. Please see the User Guide for more information.